Literature DB >> 22338582

Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.

Andrew Stuart Gibbons1, Elizabeth Scarr, Simone Boer, Tammie Money, Won-Je Jeon, Chris Felder, Brian Dean.   

Abstract

These studies were undertaken to investigate the selectivity of cortical muscarinic receptor radioligand binding in muscarinic M(1) and M(4) receptor knockout mice and to determine whether a marked decrease in [(3)H]pirenzepine binding in Brodmann's area (BA) 9 from a subset of people with schizophrenia was predictive of decreased muscarinic receptors in other central nervous system (CNS) regions. Our data show that, under the conditions used, [(3)H]pirenzepine binding was highly selective for the muscarinic M(1) receptor whereas both [(3)H]AF-DX 386 and [(3)H]4DAMP had less discriminatory power. In addition, the data suggest that a marked decrease in [(3)H]pirenzepine binding in BA 9 from a subset of people with schizophrenia is predictive of decreases in muscarinic receptors in other CNS regions. However, there were some region-specific decreases in muscarinic receptors in tissue from people with schizophrenia who were outside this subset. These data add to a growing body of evidence suggesting there are widespread decreases in muscarinic receptors in the CNS of some subjects with schizophrenia, as demonstrated by neuroimaging. Our data have implications for understanding the potential clinical utility of drugs directed at the orthosteric and allosteric sites of muscarinic receptors to treat schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22338582     DOI: 10.1017/S1461145712000028

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  23 in total

1.  Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice.

Authors:  R W Gould; D Dencker; M Grannan; M Bubser; X Zhan; J Wess; Z Xiang; C Locuson; C W Lindsley; P J Conn; C K Jones
Journal:  ACS Chem Neurosci       Date:  2015-08-05       Impact factor: 4.418

2.  Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.

Authors:  Elizabeth Scarr; Shaun Hopper; Valentina Vos; Myoung Suk Seo; Ian Paul Everall; Timothy Douglas Aumann; Gursharan Chana; Brian Dean
Journal:  J Psychiatry Neurosci       Date:  2018-08       Impact factor: 6.186

3.  Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations.

Authors:  Brian Dean; Shaun Hopper; P Jeffrey Conn; Elizabeth Scarr
Journal:  Neuropsychopharmacology       Date:  2015-10-29       Impact factor: 7.853

4.  Muscarinic receptor binding changes in postmortem Parkinson's disease.

Authors:  Caitlin McOmish; Geoff Pavey; Catriona McLean; Malcolm Horne; Brian Dean; Elizabeth Scarr
Journal:  J Neural Transm (Vienna)       Date:  2016-11-21       Impact factor: 3.575

5.  Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.

Authors:  A Ghoshal; J M Rook; J W Dickerson; G N Roop; R D Morrison; N Jalan-Sakrikar; A Lamsal; M J Noetzel; M S Poslusney; M R Wood; B J Melancon; S R Stauffer; Z Xiang; J S Daniels; C M Niswender; C K Jones; C W Lindsley; P J Conn
Journal:  Neuropsychopharmacology       Date:  2015-06-25       Impact factor: 7.853

Review 6.  Histamine H3 receptors and its antagonism as a novel mechanism for antipsychotic effect: a current preclinical & clinical perspective.

Authors:  Danish Mahmood
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

7.  Cognitive burden of anticholinergic medications in psychotic disorders.

Authors:  Seenae Eum; S Kristian Hill; Leah H Rubin; Ryan M Carnahan; James L Reilly; Elena I Ivleva; Sarah K Keedy; Carol A Tamminga; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Matcheri S Keshavan; Richard S E Keefe; John A Sweeney; Jeffrey R Bishop
Journal:  Schizophr Res       Date:  2017-04-06       Impact factor: 4.939

8.  Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.

Authors:  Michael D Grannan; Catharine A Mielnik; Sean P Moran; Robert W Gould; Jacob Ball; Zhuoyan Lu; Michael Bubser; Amy J Ramsey; Masahito Abe; Hyekyung P Cho; Kellie D Nance; Anna L Blobaum; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2016-10-05       Impact factor: 4.418

9.  Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.

Authors:  Elizabeth Scarr; Catriona McLean; Brian Dean
Journal:  J Neural Transm (Vienna)       Date:  2016-09-29       Impact factor: 3.575

Review 10.  The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.

Authors:  Tomasz Boczek; Joanna Mackiewicz; Marta Sobolczyk; Julia Wawrzyniak; Malwina Lisek; Bozena Ferenc; Feng Guo; Ludmila Zylinska
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.